发明名称 Methods to measure dissociation rates for ligands that form reversible covalent bonds
摘要 The crystal structure of the ligand binding domain of ERR-α in complex with a ligand that forms a reversible thioether bond to Cys325 of ERR-α, methods to measure dissociation rates for ligands that form reversible covalent bonds, and methods to design ligands that form reversible covalent bonds for use as modulators of ERR-α activity are disclosed. The crystal structure and methods provide a novel molecular mechanism for modulation of the activity of ERR-α and provide the basis for rational drug design to obtain potent specific ligands for use as modulators of the activity of this new drug target.
申请公布号 US8927297(B2) 申请公布日期 2015.01.06
申请号 US201012850117 申请日期 2010.08.04
申请人 Janssen Pharmaceutica N.V. 发明人 Rentzeperis Dionisios;Abad Marta Cristina;Barnakova Ludmila A.;Lewandowski Frank A.;Milligan Cynthia M.
分类号 G01N33/53;G01N33/68 主分类号 G01N33/53
代理机构 代理人 Brock Sean C.
主权项 1. A method to measure the dissociation rate of a ligand that forms a reversible covalent bond with a protein, wherein said protein is an Estrogen Related Receptor alpha (ERR-α), comprising the steps of: (a) measuring by LC/MS a mass for the protein, a mass for a first ligand that forms a reversible covalent thioether bond with the protein at Cys325, and a mass for a competing second ligand that forms a reversible covalent bond with the protein, wherein the competing second ligand has a different mass than the first ligand; (b) mixing the protein and the first ligand in a solution with the first ligand in molar excess of the protein; (c) incubating the protein and the first ligand in the solution to allow for a protein:ligand complex to form; (d) removing an aliquot of the solution and measuring by LC/MS the mass for the protein:ligand complex; (e) adding the competing second ligand to the solution containing the protein:ligand complex, wherein the competing second ligand is in molar excess to the protein:ligand complex and in molar excess to the first ligand; (f) removing aliquots of the solution at time 0 and at regular time intervals; (g) measuring the time-dependent change in the mass of the protein:ligand complex equal to the mass difference of the first ligand and the competing second ligand; and, (h) determining the dissociation rate for the first ligand.
地址 Beerse BE